Alpha-Synucleinopathy-Associated Neurons

📖 Wiki Page

cell1115 wordssynced 2026-04-02

Alpha-Synucleinopathy-Associated Neurons

...

Alpha-Synucleinopathy-Associated Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Alpha-Synucleinopathy-Associated Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000095](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000095)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000095](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000095)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0004117](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004117)</td>
</tr>
<tr>
<td class="label">Stage</td>
<td>Species</td>
</tr>
<tr>
<td class="label">1</td>
<td>Monomeric α-Syn</td>
</tr>
<tr>
<td class="label">2</td>
<td>Oligomeric α-Syn</td>
</tr>
<tr>
<td class="label">3</td>
<td>Protofibrils</td>
</tr>
<tr>
<td class="label">4</td>
<td>Fibrils</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Effect on α-Syn Pathology</td>
</tr>
<tr>
<td class="label">SNCA multiplication</td>
<td>Increased expression, earlier onset</td>
</tr>
<tr>
<td class="label">GBA1 mutations</td>
<td>Higher burden, faster progression</td>
</tr>
<tr>
<td class="label">LRRK2 mutations</td>
<td>Variable effects</td>
</tr>
<tr>
<td class="label">PARK2/PARKIN</td>
<td>Less Lewy bodies (paradox)</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Example</td>
</tr>
<tr>
<td class="label">Aggregation inhibitors</td>
<td>Anle138b</td>
</tr>
<tr>
<td class="label">Immunotherapy</td>
<td>Prasinezumab</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-AADC</td>
</tr>
<tr>
<td class="label">Cell replacement</td>
<td>iPSC-dopamine</td>
</tr>
<tr>
<td class="label">Stage</td>
<td>Affected Regions</td>
</tr>
<tr>
<td class="label">1</td>
<td>DMV, LC</td>
</tr>
<tr>
<td class="label">2</td>
<td>Lower brainstem</td>
</tr>
<tr>
<td class="label">3</td>
<td>SNc, amygdala</td>
</tr>
<tr>
<td class="label">4</td>
<td>Temporal cortex</td>
</tr>
<tr>
<td class="label">5-6</td>
<td>Neocortex</td>
</tr>
</table>

Overview

Mermaid diagram (expand to render)

Alpha Synucleinopathy Associated Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

Morphology: neuron associated cell (source: Cell Ontology)
Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0000095)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000095)
[OBO Foundry (CL:0000095)](http://purl.obolibrary.org/obo/CL_0000095)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:0000095)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000095)
[OBO Foundry (CL:0000095)](http://purl.obolibrary.org/obo/CL_0000095)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)

Introduction

Alpha-synucleinopathy-associated neurons are neurons that accumulate pathological alpha-synuclein (α-Syn) aggregates in the form of Lewy bodies and Lewy neurites. These proteinaceous inclusions characterize a group of neurodegenerative diseases collectively termed synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA)[@spillantini1997][@braak2003]. Understanding which neuronal populations are vulnerable to alpha-synuclein pathology, and why, is critical for developing disease-modifying therapies.

Vulnerable Neuronal Populations

Substantia Nigra Pars Compacta

The most prominently affected region in PD[@kalia2015]:

Dopaminergic neurons: 50-70% loss by clinical diagnosis
Neuromelanin-containing neurons: Selective vulnerability
A9 neurons: Most affected
A10 neurons: Relatively spared

Why SNc Neurons Are Vulnerable

High oxidative metabolism: Dopamine auto-oxidation

Neuromelanin accumulation: Iron chelation and pro-oxidant

Pacemaker activity: Calcium influx

Long axons: Transport burden

Mitochondrial stress: Complex I deficiency

Limbic System

Early involvement in disease progression:

Hippocampal CA2/3 neurons: Memory circuit disruption
Amygdala neurons: Emotional processing deficits
Entorhinal cortex: Grid cell dysfunction
Subiculum: Output pathway

Lower Brainstem

Pathological staging reveals early involvement:

Dorsal motor nucleus of vagus (DMN): Stage 1 involvement
Locus coeruleus: Noradrenergic neurons
Raphe nuclei: Serotonergic neurons
Pedunculopontine nucleus: Gait dysfunction

Peripheral Nervous System

Enteric nervous system: GI tract involvement
Vagus nerve: Prion-like spread hypothesis
Sympathetic ganglia: Cardiac denervation
Salivary glands: Early biomarker source

Cortical Regions

Frontal cortex: Executive dysfunction
Temporal cortex: Language deficits
Parietal cortex: Visuospatial impairment
Primary sensory areas: Sensory processing

Molecular Pathology

Alpha-Synuclein Aggregation Cascade

The pathological process involves protein misfolding and aggregation[@lashuel2013]:

Lewy Body Composition

Phosphorylated α-Syn (Ser129): Major component
Ubiquitinated proteins: Degradation attempts
Neurofilaments: Scaffold proteins
Molecular chaperones: Hsp70, Hsp90

Strain Diversity

Different α-Syn strains:

PD-type: Cortical, diffuse
MSA-type: Glial cytoplasmic inclusions
DLB-type: Limbic, cortical

Genetic Modifiers

Risk Factors

Protective Factors

SNCA promoter variants: Reduced expression
LRRK2 G2019S: May reduce pathology (controversial)

Cell Death Mechanisms

Primary Pathways

Mitochondrial dysfunction:

Complex I inhibition
ATP depletion
ROS generation

ER stress:

Unfolded protein response
CHOP activation
Apoptosis

Oxidative stress:

Dopamine oxidation
Lipid peroxidation
DNA damage

Membrane pore formation:

Oligomeric α-Syn pores
Calcium dysregulation
Homeostasis failure

Transport disruption:

Axonal transport defects
Mitochondrial trafficking
Synaptic dysfunction

Neuronal Vulnerability Factors

Intrinsic Factors

Metabolic demand: High energy requirements
Calcium handling: Pacemaker activity
Protein clearance: Age-related decline
Axonal length: Transport burden
Neuromelanin: Iron accumulation

Extrinsic Factors

Microglial activation: Neuroinflammation
Vascular supply: Perfusion deficits
Network activity: Functional demands

Therapeutic Implications

Disease-Modifying Strategies

Neuroprotective Approaches

Antioxidants: CoQ10, vitamin E, edaravone
Calcium channel blockers: L-type blockers
GLP-1 agonists: Exenatide (clinical trials)
Mitochondrial protectants: MitoQ

Symptomatic Treatments

Dopamine replacement: L-DOPA, agonists
Monoamine oxidase B inhibitors: Selegiline, rasagiline
COMT inhibitors: Entacapone

Braak Staging

The progression of α-Syn pathology follows a characteristic pattern[@del2016]:

Research Methods

Biomarker Development

CSF α-Syn: Phospho-Ser129
Skin biopsies: Autonomic nerves
Olfactory testing: Early detection
PET ligands: In vivo imaging

Model Systems

Transgenic mice: A53T, A30P
Viral vectors: AAV-SNCA
iPSC neurons: Patient-derived
Organoids: 3D models

Key Publications

[Spillantini MG, et al. Alpha-synuclein in Lewy bodies. Nature. 1997](https://doi.org/10.1038/42166)

[Braak H, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003](https://doi.org/10.1016/s0197-4580(02)00065-9)

[Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015](https://doi.org/10.1016/S0140-6736(14)61393-3)

[Lashuel HA, et al. The many faces of alpha-synuclein. J Mol Biol. 2013](https://doi.org/10.1016/j.jmb.2013.04.007)

[Peelaerts W, et al. Alpha-Synuclein strains. Nature. 2015](https://doi.org/10.1038/nature14547)

Parkinson Disease
[Dementia with Lewy Bodies](/diseases/lewy-body-dementia)
[Multiple System Atrophy](/diseases/multiple-system-atrophy)
[Alpha-Synuclein](/proteins/alpha-synuclein) SNCA Gene
Substantia Nigra
Lewy Bodies

Overview

Background

The study of Alpha Synucleinopathy Associated Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[Lewy Body Dementia Association](https://www.lbda.org/)
[Michael J. Fox Foundation](https://www.michaeljfox.org/)
[Parkinson's Foundation](https://www.parkinson.org/)
[Alpha-Synuclein Research - NIH](https://www.ninds.nih.gov/)

Pathway Diagram

The following diagram shows the key molecular relationships involving Alpha-Synucleinopathy-Associated Neurons discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →